HomeDC4 • FRA
add
DexCom Inc
Previous close
€65.90
Day range
€65.17 - €65.17
Year range
€52.00 - €87.00
Market cap
29.96B USD
Avg Volume
35.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.16B | 15.21% |
Operating expense | 476.20M | 1.60% |
Net income | 179.80M | 25.30% |
Net profit margin | 15.54 | 8.75% |
Earnings per share | 0.48 | 11.63% |
EBITDA | 275.60M | 31.18% |
Effective tax rate | 25.43% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.93B | -6.13% |
Total assets | 7.33B | 7.76% |
Total liabilities | 4.75B | 8.91% |
Total equity | 2.57B | — |
Shares outstanding | 392.16M | — |
Price to book | 10.05 | — |
Return on assets | 7.55% | — |
Return on capital | 10.63% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 179.80M | 25.30% |
Cash from operations | 303.00M | 8.45% |
Cash from investing | -63.60M | 66.33% |
Cash from financing | -1.70M | -21.43% |
Net change in cash | 254.20M | 188.54% |
Free cash flow | 165.64M | -33.63% |
About
DexCom, Inc. is an American healthcare company that develops, manufactures, produces, and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland. Wikipedia
Founded
1999
Headquarters
Website
Employees
10,250
